SHT publicerade den 20 augusti 2022 bolagets delårsrapport för andra kvartalet 2022.
Managed to beat ABGSCe by 18% in tough conditions We lift our ’22e-’24e sales estimates by 5-9% Fair...
Etteplan announced a recommended cash offer for Swedish technology company Semcon.
Redeye comments on Zordix Q2-results which came in stronger than expected driven by a strong gross m...
Redeye sees a report that showed considerably stronger sales development in the quarter than expecte...
Redeye comments on W5’s Q2-results which came in stronger than expected despite supply chain challen...
No material updates, presentation today at 10:00 CET Cash at SEK 322.
Lumito står i startgropen för en produktlansering. Bolaget, som utvecklat en teknik för bättre bildt...
Redeye makes minor forecast adjustments following Binero’s Q2’22 report.
Redeye lowers its valuation of QleanAir following a weak Q2’22 report.
Redeye comments on today’s Q2 report from Annexin Pharmaceuticals and largely reiterate our view of ...
Imint continued to grow sales rapidly during the second quarter of 2022, but with lower margins than...
Redeye comments on Isofol’s Q2 2022 report, roughly three weeks after the company communicated that ...
Recyctec publicerade idag den 23 augusti bolagets delårsrapport för Q2-22.
Sales and adj. EBITA 20% and 12% vs. ABGSCe Organic growth of 23% vs.
Etteplan offers SEK 149 per Semcon’s share, which is 32% over yesterdays’ close price.
Etteplan offers SEK 149 per share Has the backing of ~47% of current shareholders Acceptance perio...
Bolaget uppvisade stigande omsättning och god kostnadskontroll under Q2.
Alltainer AB (”Alltainer” eller ”Bolaget”) presenterade nyligen sin Q4-rapport, vilken i sig inte in...
Höga engångskostnader efter börsnoteringen i kombination med ett osäkert omvärldsläge, vilket antas ...
